financetom
Business
financetom
/
Business
/
Dynavax Technologies to Repurchase $100 Million From Goldman Sachs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dynavax Technologies to Repurchase $100 Million From Goldman Sachs
Nov 11, 2024 6:19 AM

08:43 AM EST, 11/11/2024 (MT Newswires) -- Dynavax Technologies ( DVAX ) said Monday it signed a deal with Goldman Sachs ( GS ) to repurchase $100 million of shares under an accelerated share repurchase transaction, or ASR.

The transaction is part of Dynavax's ( DVAX ) $200 million share repurchase program launched this month, the company said. After the ASR is completed, Dynavax ( DVAX ) will have $100 million remaining under the buyback.

Dynavax ( DVAX ) said it will pay $100 million to Goldman Sachs ( GS ) to initially receive approximately 6.1 million shares. The final number to be repurchased will be based on volume-weighted average prices of the company's stock during the term of the ASR, the company said.

The final settlement of the ASR is expected to be completed in Q1 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Koppers Holdings Insider Sold Shares Worth $583,867, According to a Recent SEC Filing
Koppers Holdings Insider Sold Shares Worth $583,867, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- James A. Sullivan, President and COO, on March 01, 2024, sold 10,714 shares in Koppers Holdings ( KOP ) for $583,867. Following the Form 4 filing with the SEC, Sullivan has control over a total of 111,192 shares of the company, with 111,192 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1315257/000095017024026233/xslF345X03/ownership.xml Price: 53.48, Change: -0.01,...
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- John F Crowley, Director, Executive Chairman, on March 01, 2024, sold 29,181 shares in Amicus Therapeutics ( FOLD ) for $389,543. Following the Form 4 filing with the SEC, Crowley has control over a total of 638,373 shares of the company, with 573,478 shares held directly and 64,895 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178879/000095017024026265/xslF345X03/ownership.xml...
Mongodb Insider Sold Shares Worth $3,466,497, According to a Recent SEC Filing
Mongodb Insider Sold Shares Worth $3,466,497, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- Dwight A Merriman, Director, on March 01, 2024, sold 8,000 shares in Mongodb ( MDB ) for $3,466,497. Following the Form 4 filing with the SEC, Merriman has control over a total of 1,780,680 shares of the company, with 1,160,784 shares held directly and 619,896 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1441816/000144181624000042/xslF345X03/wk-form4_1709676677.xml Price: 411.49, Change:...
Squarespace Insider Sold Shares Worth $327,500, According to a Recent SEC Filing
Squarespace Insider Sold Shares Worth $327,500, According to a Recent SEC Filing
Mar 5, 2024
05:15 PM EST, 03/05/2024 (MT Newswires) -- Paul Gubbay, Chief Product Officer, on March 04, 2024, sold 10,000 shares in Squarespace ( SQSP ) for $327,500. Following the Form 4 filing with the SEC, Gubbay has control over a total of 46,186 shares of the company, with 46,186 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1496963/000156218024002294/xslF345X03/primarydocument.xml Price: 31.33, Change: -0.63, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved